Triangle Securities Wealth Management Sells 240 Shares of The Procter & Gamble Company (NYSE:PG)

Triangle Securities Wealth Management lowered its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,399 shares of the company’s stock after selling 240 shares during the period. Triangle Securities Wealth Management’s holdings in Procter & Gamble were worth $2,582,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Ameritas Advisory Services LLC grew its stake in shares of Procter & Gamble by 26.1% in the fourth quarter. Ameritas Advisory Services LLC now owns 46,961 shares of the company’s stock worth $7,873,000 after acquiring an additional 9,719 shares during the period. HB Wealth Management LLC grew its position in Procter & Gamble by 3.3% in the 4th quarter. HB Wealth Management LLC now owns 216,593 shares of the company’s stock worth $36,312,000 after purchasing an additional 6,926 shares during the period. Financial & Tax Architects LLC raised its stake in Procter & Gamble by 5.2% during the 4th quarter. Financial & Tax Architects LLC now owns 38,492 shares of the company’s stock valued at $6,453,000 after buying an additional 1,893 shares during the last quarter. Trust Co. of Vermont lifted its holdings in shares of Procter & Gamble by 4.9% during the 4th quarter. Trust Co. of Vermont now owns 175,859 shares of the company’s stock valued at $29,483,000 after buying an additional 8,162 shares during the period. Finally, Cherrydale Wealth Management LLC grew its holdings in shares of Procter & Gamble by 7.3% in the fourth quarter. Cherrydale Wealth Management LLC now owns 1,947 shares of the company’s stock worth $326,000 after acquiring an additional 132 shares during the period. 65.77% of the stock is owned by institutional investors.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is owned by company insiders.

Procter & Gamble Trading Up 0.5 %

Shares of Procter & Gamble stock opened at $161.35 on Monday. The Procter & Gamble Company has a 1 year low of $146.28 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The stock has a market cap of $379.98 billion, a PE ratio of 27.82, a price-to-earnings-growth ratio of 3.41 and a beta of 0.45. The firm has a fifty day moving average price of $169.19 and a 200 day moving average price of $169.42.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.83 EPS. Equities research analysts predict that The Procter & Gamble Company will post 6.93 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.50%. Procter & Gamble’s dividend payout ratio (DPR) is 69.31%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. DA Davidson reissued a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research report on Friday, December 27th. UBS Group cut their target price on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research report on Thursday. Evercore ISI increased their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research note on Thursday. Finally, Morgan Stanley lifted their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $179.65.

Get Our Latest Stock Report on PG

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.